Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2004) 8 P64

1Department of Endocrinology, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands, U.K.; 2Department of Endocrinology, Princess Royal Hospital, Telford, Shropshire, U.K.


Carcinoid tumours are the most common neuroendocrine tumors with an estimated incidence of 7-13/ million population. The clinical symptoms of carcinoid tumours usually relate to presence of the carcinoid syndrome, local symptoms or metastases. Most are asymptomatic with only 10% manifesting the 'carcinoid syndrome'. We report an 86 year-old lady referred for evaluation of multiple subcutaneous, nodules around her neck and upper back, with a suspicion of underlying lymphoproliferative disease. The patient had noticed these painless lumps for 6 weeks. She did not complain of any systemic symptoms, but on direct questioning admitted to a history of intermittent watery diarrhoea and weight loss over the last 6 months. Biopsy of a nodule revealed a poorly differentiated high-grade malignant neoplasm. Immunohistochemistry was positive for chromogranin, CAM 5.2, CK7, AE1 and AE2, but negative for LCA, CD20, S100, UCHL-1, CK20 and melan-A. Thus it was consistent with metastatic neuroendocrine carcinoma. Cutaneous metastasis is very uncommon and usually represents terminal disease. Presentation of carcinoid tumour as cutaneous metastases is extremely rare, with only a few reported cases.

Volume 8

195th Meeting of the Society for Endocrinology joint with Diabetes UK and the Growth Factor Group

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts